IP Library › Patent Application 14537429
Patent Application
App. No. 14/537,429

METHOD FOR TREATING PROSTATITIS UTILIZING PORE-FORMING PROTEIN PROAEROLYSIN

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/537,429
Abstract

The present disclosure includes methods and compositions for treating any condition involving prostatitis and similar diseases and/or conditions. These methods and compositions involve the use of targeted modified pore-forming proteins, including variant proaerolysin proteins.

Claims (4)

1 - 20 . (canceled)

21 . A method of treating prostatitis in a subject, comprising administering to said subject a therapeutically effective amount of PRX302,

wherein the PRX302 comprises:

an amino acid sequence having greater than 98% sequence identity to the amino acid sequence shown in SEQ ID NO:3 and which maintains the ability to selectively target and kill normal prostate cells, and an affinity tag.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2016
From: NICKEL, CURTIS, DR.
To: PROTOX THERAPEUTICS, INC.
Reel/Frame 039499/0172 →
CHANGE OF NAME Recorded Aug 22, 2016
From: PROTOX THERAPEUTICS, INC.
To: SOPHIRIS BIO INC.
Reel/Frame 039499/0790 →